| Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels. | |
| | |
MedLine Citation:
|
PMID: 8120546 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: We tested whether nuclear imaging with technetium 99m-labeled murine monoclonal antibody (MoAb) against carcinoembryonic antigen (CEA) IMMU-4 will detect recurrent colorectal disease in patients with a rising serum CEA level but negative abdominal and pelvic computed tomographic (CT) scan, chest radiograph, and colonoscopy, or barium enema. PATIENTS AND METHODS: Sixteen patients with completely resected, CEA-producing colorectal cancer were given 1 mg of 99mTc-labeled IMMU-4 intravenously with no toxic side effects. Planar and single-photon emission CT (SPECT) scans were acquired at 6 hours. Fifteen patients underwent an exploratory laparotomy at 24 hours. Results of the scintigraphy were correlated with surgical findings. RESULTS: Twelve of 15 patients (80%) had true-positive (TP) scans when correlated with surgery. Two of 15 (13%) had true-negative (TN) scans inasmuch as exploratory laparotomy failed to detect recurrent disease. A false-positive (FP) scan was obtained in one of 15 (7%). There were no false-negative (FN) scans. Sensitivity, specificity, accuracy, and the positive predictive value (PPV) were 100%, 67%, 93%, and 92%, respectively. Twenty-six histologically confirmed areas of malignancy were found and correlated with areas of increased activity seen on IMMU-4 scintigraphy. Twenty-one were TP; five were not detected by scintigraphy and were thus considered to be FN. There were five FP lesions and 25 TN regions. Sensitivity, specificity, accuracy, and the PPV in these 26 cancer tissues were 81%, 83%, 82%, and 81%, respectively. The median radioactivity ratio of tumorous tissue to normal tissue was 3.33, with a range of 0.89 to 17.16. CONCLUSIONS: These results suggest that 99mTc IMMU-4 scintigraphy is an important addition to the armamentarium available for diagnostic imaging and may help detect occult metastatic cancer missed by abdominal and pelvic CT in patients with rising CEA levels. |
| | |
Authors:
|
Y Z Patt; D A Podoloff; S Curley; L Kasi; R Smith; V Bhadkamkar; C Charnsangavej |
Related Documents
:
|
16427246 - Whole body mr imaging: applications in oncology. 20623276 - Role of pet/ct in congenital histiocytosis. 17224266 - Prospective comparison of 18f-fluorodeoxyglucose positron emission tomography/computed ... 19474116 - High suv uptake on fdg-pet/ct predicts for an aggressive b-cell lymphoma in a prospecti... 16478626 - Transcranial magnetic stimulation screening for cord compression in cervical spondylosis. 7709416 - Sensitivity of magnetic resonance diffusion-weighted imaging and regional relationship ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of clinical oncology : official journal of the American Society of Clinical Oncology Volume: 12 ISSN: 0732-183X ISO Abbreviation: J. Clin. Oncol. Publication Date: 1994 Mar |
Date Detail:
|
Created Date: 1994-04-04 Completed Date: 1994-04-04 Revised Date: 2011-08-01 |
Medline Journal Info:
|
Nlm Unique ID: 8309333 Medline TA: J Clin Oncol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 489-95 Citation Subset: IM |
Affiliation:
|
Department of Gastrointestinal Medical Oncology and Digestive Diseases, University of Texas M.D. Anderson Cancer Center, Houston 77030. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Antibodies, Monoclonal / diagnostic use* Carcinoembryonic Antigen / blood*, immunology* Colorectal Neoplasms / immunology*, radionuclide imaging*, surgery Female Humans Male Middle Aged Neoplasm Recurrence, Local / radionuclide imaging* Predictive Value of Tests Radioimmunodetection* Sensitivity and Specificity Technetium / diagnostic use Tomography, Emission-Computed, Single-Photon Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Carcinoembryonic Antigen; 0/IMMU-4 monoclonal antibody; 7440-26-8/Technetium |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with progn...
Next Document: Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for ...